<DOC>
	<DOCNO>NCT02941835</DOCNO>
	<brief_summary>The PROBI phase I/II trial assess feasibility preoperative whole breast irradiation female patient low intermediate risk breast cancer , undergo breast conserve therapy , include boost dose irradiation . An additional goal study assess tumor response radiotherapy , image modality ( PET-CT MRI ) pathology</brief_summary>
	<brief_title>Preoperative Breast Irradiation</brief_title>
	<detailed_description />
	<criteria>Histologically proven invasive breast carcinoma cT12N0 breast cancer cM0 Indication additional boost tumor bed , i.e . : female patient â‰¤ 50 year AND/OR histological grade III carcinoma AND/OR lymph angio invasion plan breast conserving surgery ( without neoadjuvant systemic therapy ) Ability undergo irradiation surgery Signed write informed consent prior surgery radiotherapy protocol tumor neoadjuvant chemotherapy hormonal therapy plan oncoplastic reduction mammoplasty cTis indication additional boost tumor bed extensive calcification mammagram ( Birads 3,4 5 ) cT34 and/or cN13 invasive carcinoma distant metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>pre-operative radiotherapy</keyword>
</DOC>